PT141 KITS

Description

PT-141

PT-141, also known as Bremelanotide, is a synthetic cyclic peptide derived from melanocortin peptide research. It is studied for its interaction with melanocortin receptors and its role in neurological, endocrine, and peptide-mediated signaling pathways.

Researchers may use PT-141 in controlled laboratory environments to investigate melanocortin receptor activity, central nervous system signaling, molecular communication, receptor-binding behavior, and related biochemical mechanisms. PT-141 was the investigational name used during the development of bremelanotide.

Research Applications

• Melanocortin receptor interaction studies
• Neuropeptide signaling research
• Central nervous system pathway investigation
• Endocrine signaling studies
• Receptor-binding analysis
• Experimental peptide characterization

Product Specifications

Compound: PT-141
Alternative Name: Bremelanotide
Category: Synthetic Research Peptide
Classification: Melanocortin Receptor Research Peptide
Form: Lyophilized Powder
Purity: Refer to the current Certificate of Analysis
Intended Use: Laboratory research and analytical applications

Research Use Only

This product is supplied exclusively for legitimate laboratory research and analytical purposes. It is intended only for use by qualified professionals in controlled research environments.

Not intended for human or veterinary use, consumption, injection, administration, diagnosis, treatment, or therapeutic purposes. A prescription bremelanotide product exists, but a separately sold research product should not be represented as that FDA-approved drug or as suitable for human use.